Prelude Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Prelude Therapeutics by Bank of America Corporation
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $26k | 21k | 1.28 |
2024-09-30 | $52k | 25k | 2.07 |
2024-06-30 | $131k | 34k | 3.81 |
2024-03-31 | $153k | 32k | 4.74 |
2023-12-31 | $160k | 38k | 4.27 |
2023-09-30 | $163k | 53k | 3.09 |
2023-06-30 | $52k | 12k | 4.50 |
2023-03-31 | $161k | 28k | 5.70 |
2022-12-31 | $953k | 158k | 6.04 |
2022-06-30 | $697k | 134k | 5.22 |
2021-12-31 | $977k | 79k | 12.45 |
2021-06-30 | $145k | 5.0k | 28.80 |
2021-03-31 | $711k | 16k | 43.29 |
2020-12-31 | $35k | 490 | 71.17 |
2020-09-30 | $0 | 10 | 0.00 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation